Think Tank

Latest California Healthline Stories

What To Do About High-Priced Drugs?

According to a new analysis, California taxpayers could pay as much as $5.1 billion a year to treat hepatitis C patients in state-funded programs, adding fuel to some experts’ contention that expensive drugs may bankrupt the health system. We asked consumer advocates, insurers, state health officials and pharmaceutical manufacturers to weigh in on the issue.